Sign In
Buy MNOV
MediciNova Stock Insider Power
Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 7.3M and sold 25.29K MNOV shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
100.00 |
| ● Buy | 7.3M shares |
| ● Sell | 25.29K shares |
|
92% Buy Activity
Moderate Negative Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jan 16, 2026 Buy |
Matsuda Kazuko Chief Medical Officer |
350 000 Value: $735.0K |
||
|
Jan 16, 2026 Buy |
Iwaki Yuichi President And CEO |
450 000 Value: $945.0K |
||
|
Jun 17, 2025 Buy |
Nagao Hideki Director |
20 000 Value: $25.2K |
||
|
Jun 17, 2025 Buy |
Lemerond Nicole Director |
20 000 Value: $25.2K |
||
|
Jun 17, 2025 Buy |
Beaver Carolyn Director |
20 000 Value: $25.2K |
||
|
Jun 17, 2025 Buy |
Beaver Carolyn Director |
20 000 Value: $25.2K |
||
|
Jun 17, 2025 Buy |
Lemerond Nicole Director |
20 000 Value: $25.2K |
||
|
Jun 17, 2025 Buy |
Nagao Hideki Director |
20 000 Value: $25.2K |
||
|
Feb 12, 2025 Buy |
Nagao Hideki Director |
24 500 Value: $45.1K |
||
|
Feb 12, 2025 Buy |
Matsuda Kazuko Chief Medical Officer |
100 000 Value: $184.0K |
||
|
Feb 12, 2025 Buy |
Lemerond Nicole Director |
24 500 Value: $45.1K |
||
|
Feb 12, 2025 Buy |
Iwaki Yuichi President And CEO |
100 000 Value: $184.0K |
||
|
Feb 12, 2025 Buy |
Beaver Carolyn Director |
24 500 Value: $45.1K |
||
|
Feb 12, 2025 Buy |
Beaver Carolyn Director |
24 500 Value: $45.1K |
||
|
Feb 12, 2025 Buy |
Iwaki Yuichi President And CEO |
100 000 Value: $184.0K |
||
|
Feb 12, 2025 Buy |
Lemerond Nicole Director |
24 500 Value: $45.1K |
||
|
Feb 12, 2025 Buy |
Matsuda Kazuko Chief Medical Officer |
100 000 Value: $184.0K |
||
|
Feb 12, 2025 Buy |
Nagao Hideki Director |
24 500 Value: $45.1K |
||
|
Jan 07, 2025 Buy |
Iwaki Yuichi President And CEO |
400 000 Value: $608.0K |
||
|
Jan 07, 2025 Buy |
Matsuda Kazuko Chief Medical Officer |
300 000 Value: $456.0K |
||
|
Jan 07, 2025 Buy |
Matsuda Kazuko Chief Medical Officer |
300 000 Value: $456.0K |
||
|
Jan 07, 2025 Buy |
Iwaki Yuichi President And CEO |
400 000 Value: $608.0K |
||
|
Jun 11, 2024 Buy |
Nagao Hideki Director |
20 000 Value: $26.8K |
||
|
Jun 11, 2024 Buy |
Lemerond Nicole Director |
20 000 Value: $26.8K |
||
|
Jun 11, 2024 Buy |
Beaver Carolyn Director |
20 000 Value: $26.8K |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
